IMT1B
IMT1B (LDC203974) is an orally active, noncompetitive and specific allosteric inhibitor of mitochondrial RNA polymerase (POLRMT) and inhibits mitochondrial DNA (mtDNA) expression. IMT1B has anti-tumour effects[1].
Product Specifications
CAS Number
[2304621-06-3]
Product Name Alternative
LDC203974
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/imt1b.html
Purity
99.45
Solubility
DMSO : 200 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1CN(C([C@H](OC2=CC=C(C(O3)=C2)C(C4=CC=C(F)C=C4Cl)=CC3=O)C)=O)CCC1)O
Molecular Formula
C24H21ClFNO6
Molecular Weight
473.88
Precautions
H302, H315, H319
References & Citations
[1]Nina A Bonekamp, et al. Small-molecule inhibitors of human mitochondrial DNA transcription. Nature. 2020 Dec;588 (7839) :712-716.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
LECT1 (Leukocyte Cell-derived Chemotaxin 1, CHMI, BRICD3, MYETS1) (HRP)
LECT1 (Leukocyte Cell-derived Chemotaxin 1, CHMI, BRICD3, MYETS1) (HRP)